Cetrorelix dosing & administration

Name: Cetrorelix Injection Dosage & Protocol
Creator: Michael Carroll

Fast-acting GnRH antagonist that stops premature ovulation during IVF cycles

Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team

3 mgTypical dose

Single dose (one injection)Frequency

Subcutaneous injectionRoute

Ongoing/indefiniteCycle length

Dosing

How much do I take?

Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.

Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.

Days 4-9

0.25 mg

Frequency

Once every 24 hours

Duration

From stimulation day 5-6 until the day of hCG (about 4-9 days)

The FDA-approved multiple-dose plan. A 0.25 mg shot under the skin each day stops an early LH surge during fertility (IVF) ovarian stimulation. [5]

One dose covers at least 4 days; add 0.25 mg daily after if hCG is delayed

3 mg

Frequency

Single dose (one injection)

Duration

One dose covers at least 4 days; add 0.25 mg daily after if hCG is delayed

The FDA-approved single-dose plan. One 3 mg shot is given when estrogen levels show the follicles are ready (usually stimulation day 7). It protects against an early LH surge for at least 4 days. [5][6]

Timing

Best time to take

Administer Cetrorelix at the same time each day (or on the same day each week for weekly injections). Many users prefer morning or evening administration. Pick a time you'll remember consistently.

With food?

Cetrorelix injections can be given regardless of meal timing. However, if GI effects occur, administering on an empty stomach or with a light meal may help reduce discomfort.

If stacking

Cetrorelix should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

Adjusting your dose

Increase if

You've tolerated the current dose for the recommended period without significant side effects
Therapeutic goals haven't been met at the current dose level
Your healthcare provider recommends dose escalation based on your response
Lab work or clinical assessments support a higher dose

Decrease if

Side effects are bothersome or impacting daily life despite management strategies
You experience any signs of an adverse reaction
Lab results indicate the need for dose reduction
Your healthcare provider recommends a lower dose based on your response

Signs of right dose

Therapeutic goals being met with minimal side effects
Stable and consistent response to treatment
Lab values or clinical markers trending in the right direction
Good tolerance with manageable or absent side effects

CetrorelixOnce every 24 hours

How much peptide is in your bottle?

Look at the label on the vial. It’s the number next to mg — like "5 mg".

Administration

How do I use it?

Reconstitution

What you need

Cetrorelix vial (lyophilized powder or solution)Bacteriostatic water or sterile sodium chloride for reconstitutionAlcohol swabs for cleaning vial tops and injection sitesAppropriately sized syringes with fine-gauge needles (27-30 gauge)Sharps disposal container

Example

Add the recommended volume of bacteriostatic water to the Cetrorelix vial. Gently swirl (do not shake) until the powder is fully dissolved. The resulting solution should be clear. Calculate your individual dose based on the concentration and your prescribed amount.

Your dose of Cetrorelix is determined by your healthcare provider. Using an insulin syringe marked in units, draw up the exact amount prescribed. For example, if the reconstituted concentration is 1mg/mL and your dose is 0.5mg, draw up 0.5mL (50 units on an insulin syringe). Always double-check calculations before injection.

Full reconstitution guide

Injection

Route

Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training

Best sites

Abdomen (stomach area)—at least 2 inches from the belly button, most popular choice for self-injectionFront of thighs—middle to upper portion of the outer legBack of upper arm—outer area (may need assistance from another person)

Technique

01Wash your hands thoroughly with soap and water before handling supplies
02Clean the injection site with an alcohol swab and let it air dry completely
03Pinch a fold of skin at the chosen injection site
04Insert the needle at a 45-90 degree angle (depending on needle length and body composition)
05Inject the medication slowly and steadily over 5-10 seconds
06Release the skin fold and remove the needle, applying gentle pressure with a clean swab
07Rotate injection sites to prevent tissue irritation or lipodystrophy
08Dispose of the needle safely in a sharps container—never recap or reuse needles

Full injection guide

Storage

Before reconstitution

Store Cetrorelix in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After reconstitution

Once reconstituted, Cetrorelix should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs of degradation — discard the vial

Solution appears cloudy, discolored, or contains visible particles (should be clear)Product has been exposed to temperatures outside the recommended storage rangeProduct has been frozen (unless specifically designed for freeze-thaw stability)Expiration date has passed or reconstituted solution has exceeded its use-by dateUnusual odor, color change, or visible contamination

Sample daily schedule

As prescribed (once daily)

As prescribed by your healthcare provider injection

Site: Subcutaneous injection—rotate sites if applicable

Maintain a consistent schedule for optimal results with Cetrorelix. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.

Safety

Is it safe?

Safety profile

Cetrorelix is an FDA-approved GnRH antagonist used exclusively in assisted reproductive technology with proven safety in short-term reproductive cycles. Unlike GnRH agonists, cetrorelix lacks the initial testosterone flare, making it well-tolerated for ovarian stimulation. Primary side effects are mild and local—injection site reactions (erythema, bruising) occur in 10-20% of patients. No systemic bone loss, cardiovascular complications, or serious adverse events have been reported in the reproductive context where treatment duration is limited (typically 7-10 days). The short treatment window in IVF protocols minimizes long-term safety concerns. Hypersensitivity reactions are rare but possible.

Cetrorelix was studied through Phase 3 clinical trials specifically for IVF applications, with large multicenter randomized trials demonstrating safety and efficacy. Regulatory approval in the U.S. and Europe was based on comprehensive Phase 2 and Phase 3 data in infertile patients undergoing controlled ovarian hyperstimulation. Long-term safety data beyond the typical 1-2 week treatment cycle is limited because the drug is not used for chronic applications.

Common side effects

Experienced by some users

Injection site reactions (redness, itching, swelling)